Reference Data
| Product Name | GHK-Cu Capsule Cream |
|---|---|
| Compound | GHK-Cu / Glycyl-L-Histidyl-L-Lysine Copper Complex |
| Concentration | 2% GHK-Cu |
| Total Volume | 30ML |
| Format | Finished cream-format research product |
| Research Category | Copper peptide / extracellular matrix / formulation research |
| Research Focus | Fibroblast signaling, collagen-associated pathways, |
| Total-Content Note | Confirm the batch record to determine whether |
Reference figures are provided for research identification. Always confirm against the batch-specific Certificate of Analysis.
2% GHK-Cu / 30ML Finished Cream
GHK-Cu Capsule Cream provides a clearly labeled finished research format for controlled studies involving copper-tripeptide behavior, fibroblast response, extracellular-matrix signaling, peptide stability, cream-base compatibility, formulation uniformity, and semisolid delivery research.
Extracellular-Matrix Research
GHK-Cu is studied in fibroblast models involving collagen synthesis, extracellular-matrix accumulation, matrix metalloproteinases, tissue inhibitors of metalloproteinases, and matrix-remodeling behavior.
Proteoglycan & Glycosaminoglycan Models
Relevant to controlled investigations involving decorin, biglycan, dermatan sulfate, chondroitin sulfate, hyaluronic-acid-associated systems, and extracellular-matrix organization.
30ML Cream Format
Supplied as a finished 2% cream research product for formulation uniformity, copper-complex stability, semisolid compatibility, controlled-release, and skin-model delivery studies.
Why GHK-Cu Matters in Research
GHK is a naturally occurring tripeptide with affinity for copper ions. The copper-bound complex, GHK-Cu, has been studied in laboratory models involving fibroblast activity, collagen production, extracellular-matrix formation, matrix remodeling, inflammatory signaling, redox regulation, and tissue-response biology.
Fibroblast-culture research has evaluated GHK-Cu in relation to collagen synthesis and matrix metalloproteinase-2 expression. Other preclinical studies have examined its relationship with tissue inhibitors of metalloproteinases, glycosaminoglycan production, decorin expression, dermatan sulfate, and extracellular-matrix organization.
GHK-Cu is also relevant to formulation science. Its behavior can vary depending on copper occupancy, coordination state, pH, carrier system, labile copper content, peptide stability, excipient compatibility, and release of intact GHK-Cu compared with free copper or unbound GHK.
The 2% 30ML cream format therefore provides a useful platform for studying both the biological behavior of the copper tripeptide and the formulation characteristics of a finished semisolid research product. Human evidence remains limited, and preclinical findings should not be interpreted as established clinical or cosmetic outcomes.
- 2% GHK-Cu concentration
- 30ML finished cream format
- Copper complex of glycyl-L-histidyl-L-lysine
- Studied in fibroblast and collagen-associated pathway research
- Relevant to extracellular-matrix synthesis and remodeling models
- Applicable to MMP-2, TIMP-1, and TIMP-2 research systems
- Relevant to proteoglycan and glycosaminoglycan investigations
- Suitable for copper-peptide coordination and formulation-stability research
- Applicable to cream-base compatibility and semisolid release studies
- Reviewed for concentration clarity, finished-product presentation, documentation, and fulfillment handling
Research Applications
- GHK-Cu copper-peptide characterization
- Fibroblast-response research
- Collagen-synthesis pathway studies
- Extracellular-matrix accumulation models
- Matrix metalloproteinase research
- TIMP-associated pathway studies
- Proteoglycan-expression research
- Decorin and biglycan pathway models
- Glycosaminoglycan research
- Dermatan-sulfate and chondroitin-sulfate studies
- Redox-regulation models
- Inflammatory-signaling research
- Copper-coordination chemistry
- Peptide-copper speciation studies
- Cream-base compatibility research
- Finished-formulation uniformity testing
- Semisolid release-behavior research
- Skin-model permeation and delivery studies
- Finished-product stability investigations
Understanding the 2% Concentration
In a cream formulation, 2% commonly refers to weight per weight. Under a 2% w/w specification, the finished product contains 20MG of GHK-Cu per gram of cream.
If the manufacturing record instead defines the formula as 2% w/v or 20MG/ML, a 30ML container would provide 600MG total GHK-Cu. If the product is defined as 2% w/w, exact total milligrams require the finished net weight or verified product density.
The product label, batch formula, Certificate of Analysis, and manufacturing documentation should use the same concentration basis. This prevents a percentage specification from being incorrectly converted into total milligrams.
Important Research Limitations
Much of the biological evidence for GHK-Cu comes from cell-culture, animal-model, ex-vivo, or formulation research. Human studies are limited, frequently small, and often do not fully characterize copper occupancy, labile copper, intact-complex exposure, formulation stability, or local delivery.
Results observed with raw GHK-Cu, injectable research preparations, microneedle systems, serums, hydrogels, or other experimental carriers should not automatically be attributed to this finished 2% cream. Formulation composition can materially affect stability, delivery, and biological interpretation.
The terms “Capsule Cream” and “2% GHK-Cu” identify the product and its labeled formulation. They do not establish skin rejuvenation, hair growth, wound repair, scar reduction, anti-aging effects, therapeutic benefit, or any other clinical outcome.
Why Our Quality Process Is Different
Copper-peptide cream research products require more oversight than a basic ingredient listing. Concentration basis, peptide identity, copper coordination, formulation uniformity, excipient compatibility, finished appearance, documentation, label accuracy, storage expectations, packaging quality, and fulfillment handling all matter.
Disguised Alpha reviews GHK-Cu Capsule Cream as a complete finished research product with attention to the 2% concentration specification, 30ML container presentation, cream consistency, batch documentation, internal QA, labeling accuracy, storage expectations, and direct fulfillment accountability.
- Clear 2% concentration labeling
- Concentration-basis review: w/w versus w/v
- GHK-Cu identity documentation review
- Copper-peptide formulation review
- Finished cream consistency checks
- Container and label presentation review
- Batch documentation and COA review
- Storage expectation review
- Internal QA before product release
- Direct in-house fulfillment with no anonymous 3PL handling
Verify Our Claims
Researchers should verify compound identity, concentration basis, formulation specifications, and batch documentation before beginning any study. Learn more about the independent laboratories we work with below.
Visit ILS Labs
Visit Chromate
The Disguised Alpha Standard
Disguised Alpha is built around direct accountability. Every order is processed, inspected, packaged, and shipped by our in-house team instead of being passed off to a third-party logistics warehouse.
This gives us tighter control over finished-product presentation, documentation, fulfillment accuracy, packaging standards, storage conditions, and customer experience. Our goal is not to be the cheapest research supplier — it is to provide professionally handled research materials with real quality oversight behind them.
GHK-Cu 2% Capsule Cream is sold strictly for laboratory and in-vitro research. It is not for human consumption, veterinary use, or any diagnostic or therapeutic application. Nothing on this page is medical, dosing, or therapeutic advice.